Figure 1.

European Neuroendocrine Tumor Society (ENETS) Expert Consensus and Recommendations for Best Practice for Typical and Atypical Pulmonary Carcinoid [26]. (A): ENETS recommendations for the control of hormone-related symptoms. (B): ENETS recommendations for the control of hormone-related symptoms and tumor growth. ^aProgression is defined according to Response Evaluation Criteria in Solid Tumors. Reprinted with permission from: Caplin ME, Baudin E, Ferolla P et al. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol 2015;26:1604–1620 (published by Oxford University Press on behalf of the European Society for Medical Oncology).

Abbreviations: AC, atypical carcinoid; PRRT, peptide receptor radionuclide therapy; TC, typical carcinoid.